CLL | Tumor

Survivorship Planning

February 20th 2019

Understanding CLL as a chronic disease.

Before Treatment

February 20th 2019

Knowing treatment options and the possibilities of supportive care.

During Treatment

February 20th 2019

Utilizing clinical trials and understanding potential side effects and complications.

After Treatment

February 20th 2019

Finding follow-up care and emotional support.

Caregiving

February 20th 2019

Serving as a caregiver for a loved one going through a CLL diagnosis and treatment while utilizing resources to take care of oneself.

Important Resources

February 20th 2019

A list of helpful resources to assist people with CLL and their families cope with the emotional and practical aspects of the disease.

Imbruvica May Be Superior to Standard of Care in Elderly Patients with CLL

February 11th 2019

Imbruvica (ibrutinib) may be superior to standard of care in elderly patients with untreated chronic lymphocytic leukemia (CLL), according to phase 3 findings published in the New England Journal of Medicine.

Expert Discusses Copiktra for Relapsed/Refractory CLL

February 6th 2019

Ian W. Flinn, M.D., Ph.D., discusses the use of Copiktra, which was approved in September for patients with relapsed/refractory chronic lymphocytic leukemia.

FDA Approves First Non-Chemotherapy Combo for Treatment-naive CLL

January 28th 2019

The Food and Drug Administration approved Imbruvica plus Gazyva for treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Two Doctors on a Similar Path to Help Those with CLL

January 24th 2019

In this week’s episode of CURE Talks Cancer, we spoke with two doctors honored for their efforts to improve the quality of life for those affected by chronic lymphocytic leukemia (CLL).

Cure: Is it Possible for CLL?

January 10th 2019

Will the word "cure" be used for patients with chronic lymphocytic leukemia (CLL)?

Physician Turns Personal Diagnosis to Educational Opportunity

January 5th 2019

Brian Koffman is a family physician who used his own CLL diagnosis to start a group that informs other patients and their loved ones.

Navigating Through CLL Treatment

December 27th 2018

CLL Management: Establishing a Network of Support

December 27th 2018

Managing Side Events From Targeted Therapy for CLL

December 27th 2018

Danise: Experience With Venetoclax Targeted Therapy

December 27th 2018

Considering a Clinical Trial for CLL Treatment

December 27th 2018

Clinical Trial Participation in CLL

December 27th 2018

Chemoimmunotherapy in CLL

December 27th 2018

Tests Used to Inform Treatment Decisions in CLL

December 27th 2018

Indications for Initiating Therapy in CLL

December 27th 2018

Role of Watchful Waiting in CLL

December 27th 2018

Confirming a Diagnosis of CLL

December 27th 2018

Moving the Paradigm of CLL Management Forward

December 27th 2018

Impacting CLL Management With Lifestyle Modification

December 27th 2018

Relapsed CLL: Factors in Choosing Therapy

December 27th 2018

Understanding the Timing of Therapy in CLL

December 27th 2018

Chronic Lymphocytic Leukemia: Selecting Initial Therapy

December 27th 2018

What Testing is Done Alongside a Diagnosis of CLL?

December 27th 2018

Imbruvica Regimen Improves Survival Outcomes in Younger Patients with CLL

December 19th 2018

The combination use of Imbruvica (ibrutinib) with Rituxan (rituximab) significantly improved survival outcomes compared with standard of care in younger patients with chronic lymphocytic leukemia (CLL).